May 26, 2017 - Stand Up To Cancer Issues Call for Ideas for $10 Million “Convergence 2.0” Teams to Address Key Questions About the Immune System’s Role in Cancer Development and Treatment
May 24, 2017 - Scientists on the SU2C-Cancer Research Institute Cancer Immunology Dream Team and the SU2C-Melanoma Research Institute Melanoma Dream Team have separately reported findings that provide new insights into melanoma, the deadliest form of skin cancer, and could help solve the puzzle of resistance to existing therapies and pave the way for development of new treatments.
May 17, 2017 - Stand Up To Cancer announces the winners of the 100 science awards.
May 16, 2017 - Stand Up To Cancer announced today a second SU2C Catalyst™ collaboration with Genentech, a member of the Roche Group, aimed at accelerating the development of new cancer treatments and combination therapies through clinical trials using Genentech medicines, including both commercial and pre-commercial treatments.
May 11, 2017 - SU2C will match Donations to No More Kids with Cancer "Mustard Challenge", up to $6 million